Hologic ( HOLX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.2%. By the end of trading, Hologic rose 13 cents (0.7%) to $18.32 on light volume. Throughout the day, 2.5 million shares of Hologic exchanged hands as compared to its average daily volume of 3.8 million shares. The stock ranged in a price between $18.19-$18.50 after having opened the day at $18.36 as compared to the previous trading day's close of $18.19. Other companies within the Health Care sector that increased today were: Sunshine Heart ( SSH), up 37.8%, BioMimetic Therapeutics ( BMTI), up 23.6%, K-V Pharmaceutical Company ( KV.A), up 13.3%, and Hooper Holmes ( HH), up 12.1%.

Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. Hologic has a market cap of $4.84 billion and is part of the health services industry. The company has a P/E ratio of 21, below the average health services industry P/E ratio of 107.6 and above the S&P 500 P/E ratio of 17.7. Shares are up 3.9% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Hologic a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income.

On the negative front, MAKO Surgical Corporation ( MAKO), down 43.1%, Rexahn Pharmaceuticals ( RNN), down 31%, Questcor Pharmaceuticals ( QCOR), down 21.8%, and Stereotaxis ( STXS), down 15.3%, were all losers within the health care sector with Intuitive Surgical ( ISRG) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).